APO Research
Talk to an analyst

APO RESEARCH · REPORT

Low Molecular Weight Heparin Sodium

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Low Molecular Weight Heparin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025188 pages

Choose your research edition.

Industry ResearchLow Molecular Weight Heparin Sodium Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Low Molecular Weight Heparin Sodium Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Low Molecular Weight Heparin Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Low Molecular Weight Heparin Sodium Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Low Molecular Weight Heparin Sodium Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Low Molecular Weight Heparin Sodium market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Low Molecular Weight Heparin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Low Molecular Weight Heparin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Low Molecular Weight Heparin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Low Molecular Weight Heparin Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Low Molecular Weight Heparin Sodium include Yantai Dongcheng Pharmaceutical Group, Changzhou Qianhong Bio-pharma, Pfizer, Dongying Tiandong Pharmaceutica, Techdow, Sanofi-aventis, Opocrin, CSBIO and Aspen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Low Molecular Weight Heparin Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Low Molecular Weight Heparin Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Low Molecular Weight Heparin Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Low Molecular Weight Heparin Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.

Low Molecular Weight Heparin Sodium Segment by Company

Yantai Dongcheng Pharmaceutical Group

Changzhou Qianhong Bio-pharma

Pfizer

Dongying Tiandong Pharmaceutica

Techdow

Sanofi-aventis

Opocrin

CSBIO

Aspen

Low Molecular Weight Heparin Sodium Segment by Type

Enoxaparin

Tinzaparin

Fraxiparine

Dalteparin

Low Molecular Weight Heparin Sodium Segment by Application

Medical

Research

Low Molecular Weight Heparin Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Low Molecular Weight Heparin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Low Molecular Weight Heparin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Low Molecular Weight Heparin Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Low Molecular Weight Heparin Sodium market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Low Molecular Weight Heparin Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Low Molecular Weight Heparin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Low Molecular Weight Heparin Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Low Molecular Weight Heparin Sodium Industry Trends Table 2. Low Molecular Weight Heparin Sodium Industry Drivers Table 3. Low Molecular Weight Heparin Sodium Industry Opportunities and Challenges Table 4. Low Molecular Weight Heparin Sodium Industry Restraints Table 5. Global Low Molecular Weight Heparin Sodium Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Low Molecular Weight Heparin Sodium Sales by Manufacturers (k tons) & (2021-2026) Table 8. Global Low Molecular Weight Heparin Sodium Sales Market Share by Manufacturers Table 9. Global Low Molecular Weight Heparin Sodium Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global Low Molecular Weight Heparin Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Low Molecular Weight Heparin Sodium Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Low Molecular Weight Heparin Sodium Manufacturers, Product Type & Application Table 13. Global Low Molecular Weight Heparin Sodium Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Low Molecular Weight Heparin Sodium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Enoxaparin Table 17. Major Manufacturers of Tinzaparin Table 18. Major Manufacturers of Fraxiparine Table 19. Major Manufacturers of Dalteparin Table 20. Global Low Molecular Weight Heparin Sodium Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 21. Global Low Molecular Weight Heparin Sodium Sales by Type (2021-2026) & (k tons) Table 22. Global Low Molecular Weight Heparin Sodium Sales by Type (2027-2032) & (k tons) Table 23. Global Low Molecular Weight Heparin Sodium Sales Market Share by Type (2021-2026) Table 24. Global Low Molecular Weight Heparin Sodium Sales Market Share by Type (2027-2032) Table 25. Global Low Molecular Weight Heparin Sodium Revenue by Type 2021 VS 2025 VS 2032 (k tons) Table 26. Global Low Molecular Weight Heparin Sodium Revenue by Type (2021-2026) & (k tons) Table 27. Global Low Molecular Weight Heparin Sodium Revenue by Type (2027-2032) & (k tons) Table 28. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2021-2026) Table 29. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Medical Table 31. Major Manufacturers of Research Table 32. Global Low Molecular Weight Heparin Sodium Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 33. Global Low Molecular Weight Heparin Sodium Sales by Application (2021-2026) & (k tons) Table 34. Global Low Molecular Weight Heparin Sodium Sales by Application (2027-2032) & (k tons) Table 35. Global Low Molecular Weight Heparin Sodium Sales Market Share by Application (2021-2026) Table 36. Global Low Molecular Weight Heparin Sodium Sales Market Share by Application (2027-2032) Table 37. Global Low Molecular Weight Heparin Sodium Revenue by Application 2021 VS 2025 VS 2032 (k tons) Table 38. Global Low Molecular Weight Heparin Sodium Revenue by Application (2021-2026) & (k tons) Table 39. Global Low Molecular Weight Heparin Sodium Revenue by Application (2027-2032) & (k tons) Table 40. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2021-2026) Table 41. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2027-2032) Table 42. Global Low Molecular Weight Heparin Sodium Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 43. Global Low Molecular Weight Heparin Sodium Sales by Region (2021-2026) & (k tons) Table 44. Global Low Molecular Weight Heparin Sodium Sales Market Share by Region (2021-2026) Table 45. Global Low Molecular Weight Heparin Sodium Sales Forecasted by Region (2027-2032) & (k tons) Table 46. Global Low Molecular Weight Heparin Sodium Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Low Molecular Weight Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 48. North America Low Molecular Weight Heparin Sodium Sales by Country (2021-2026) & (k tons) Table 49. North America Low Molecular Weight Heparin Sodium Sales by Country (2027-2032) & (k tons) Table 50. Europe Low Molecular Weight Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 51. Europe Low Molecular Weight Heparin Sodium Sales by Country (2021-2026) & (k tons) Table 52. Europe Low Molecular Weight Heparin Sodium Sales by Country (2027-2032) & (k tons) Table 53. Asia Pacific Low Molecular Weight Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 54. Asia Pacific Low Molecular Weight Heparin Sodium Sales by Country (2021-2026) & (k tons) Table 55. Asia Pacific Low Molecular Weight Heparin Sodium Sales by Country (2027-2032) & (k tons) Table 56. South America, Middle East and Africa Low Molecular Weight Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 57. South America, Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Country (2021-2026) & (k tons) Table 58. South America, Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Country (2027-2032) & (k tons) Table 59. Global Low Molecular Weight Heparin Sodium Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Low Molecular Weight Heparin Sodium Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Low Molecular Weight Heparin Sodium Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Region (2021-2026) Table 63. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Region (2027-2032) Table 64. Yantai Dongcheng Pharmaceutical Group Company Information Table 65. Yantai Dongcheng Pharmaceutical Group Business Overview Table 66. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Product Portfolio Table 68. Yantai Dongcheng Pharmaceutical Group Recent Development Table 69. Changzhou Qianhong Bio-pharma Company Information Table 70. Changzhou Qianhong Bio-pharma Business Overview Table 71. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Product Portfolio Table 73. Changzhou Qianhong Bio-pharma Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Low Molecular Weight Heparin Sodium Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pfizer Low Molecular Weight Heparin Sodium Product Portfolio Table 78. Pfizer Recent Development Table 79. Dongying Tiandong Pharmaceutica Company Information Table 80. Dongying Tiandong Pharmaceutica Business Overview Table 81. Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Product Portfolio Table 83. Dongying Tiandong Pharmaceutica Recent Development Table 84. Techdow Company Information Table 85. Techdow Business Overview Table 86. Techdow Low Molecular Weight Heparin Sodium Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Techdow Low Molecular Weight Heparin Sodium Product Portfolio Table 88. Techdow Recent Development Table 89. Sanofi-aventis Company Information Table 90. Sanofi-aventis Business Overview Table 91. Sanofi-aventis Low Molecular Weight Heparin Sodium Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Sanofi-aventis Low Molecular Weight Heparin Sodium Product Portfolio Table 93. Sanofi-aventis Recent Development Table 94. Opocrin Company Information Table 95. Opocrin Business Overview Table 96. Opocrin Low Molecular Weight Heparin Sodium Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Opocrin Low Molecular Weight Heparin Sodium Product Portfolio Table 98. Opocrin Recent Development Table 99. CSBIO Company Information Table 100. CSBIO Business Overview Table 101. CSBIO Low Molecular Weight Heparin Sodium Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. CSBIO Low Molecular Weight Heparin Sodium Product Portfolio Table 103. CSBIO Recent Development Table 104. Aspen Company Information Table 105. Aspen Business Overview Table 106. Aspen Low Molecular Weight Heparin Sodium Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Aspen Low Molecular Weight Heparin Sodium Product Portfolio Table 108. Aspen Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Low Molecular Weight Heparin Sodium Distributors List Table 112. Low Molecular Weight Heparin Sodium Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Low Molecular Weight Heparin Sodium Product Image Figure 2. Global Low Molecular Weight Heparin Sodium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Low Molecular Weight Heparin Sodium Market Size (2021-2032) & (US$ Million) Figure 4. Global Low Molecular Weight Heparin Sodium Sales (2021-2032) & (k tons) Figure 5. Global Low Molecular Weight Heparin Sodium Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 Low Molecular Weight Heparin Sodium Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Enoxaparin Image Figure 9. Tinzaparin Image Figure 10. Fraxiparine Image Figure 11. Dalteparin Image Figure 12. Global Low Molecular Weight Heparin Sodium Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 13. Global Low Molecular Weight Heparin Sodium Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Low Molecular Weight Heparin Sodium Sales Market Share by Type (2021-2032) Figure 15. Global Low Molecular Weight Heparin Sodium Revenue by Type (2021 VS 2025 VS 2032) & (k tons) Figure 16. Global Low Molecular Weight Heparin Sodium Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2021-2032) Figure 18. Medical Image Figure 19. Research Image Figure 20. Global Low Molecular Weight Heparin Sodium Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 21. Global Low Molecular Weight Heparin Sodium Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Low Molecular Weight Heparin Sodium Sales Market Share by Application (2021-2032) Figure 23. Global Low Molecular Weight Heparin Sodium Revenue by Application (2021 VS 2025 VS 2032) & (k tons) Figure 24. Global Low Molecular Weight Heparin Sodium Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2021-2032) Figure 26. North America Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 27. North America Low Molecular Weight Heparin Sodium Sales Market Share by Country (2021-2032) Figure 28. U.S. Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 29. Canada Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 30. Mexico Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 31. Europe Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 32. Europe Low Molecular Weight Heparin Sodium Sales Market Share by Country (2021-2032) Figure 33. Germany Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 34. France Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 35. U.K. Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 36. Italy Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 37. Netherlands Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 38. Asia Pacific Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 39. Asia Pacific Low Molecular Weight Heparin Sodium Sales Market Share by Country (2021-2032) Figure 40. China Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 41. Japan Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 42. South Korea Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 43. Southeast Asia Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 44. India Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 45. Australia Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 46. South America, Middle East and Africa Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 47. South America, Middle East and Africa Low Molecular Weight Heparin Sodium Sales Market Share by Country (2021-2032) Figure 48. Brazil Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 49. South Africa Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 50. Saudi Arabia Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 51. Turkey Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 52. Argentina Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 53. UAE Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 54. Egypt Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 55. Chile Low Molecular Weight Heparin Sodium Sales and Growth Rate (2021-2032) & (k tons) Figure 56. Global Low Molecular Weight Heparin Sodium Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Low Molecular Weight Heparin Sodium Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Low Molecular Weight Heparin Sodium Revenue (2021-2032) & (US$ Million) Figure 59. North America Low Molecular Weight Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Low Molecular Weight Heparin Sodium Revenue (2021-2032) & (US$ Million) Figure 61. Europe Low Molecular Weight Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Low Molecular Weight Heparin Sodium Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Low Molecular Weight Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Low Molecular Weight Heparin Sodium Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Low Molecular Weight Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Low Molecular Weight Heparin Sodium Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Low Molecular Weight Heparin Sodium Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Enoxaparin
  • Tinzaparin
  • Fraxiparine
  • Dalteparin
Applications
  • Medical
  • Research
Companies covered
  • Yantai Dongcheng Pharmaceutical Group
  • Changzhou Qianhong Bio-pharma
  • Pfizer
  • Dongying Tiandong Pharmaceutica
  • Techdow
  • Sanofi-aventis
  • Opocrin
  • CSBIO
  • Aspen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Low Molecular Weight Heparin Sodium Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Low Molecular Weight Heparin Sodium Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Low Molecular Weight Heparin Sodium Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Low Molecular Weight Heparin Sodium Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Low Molecular Weight Heparin Sodium Market Dynamics
  1. 2.1 Low Molecular Weight Heparin Sodium Industry Trends
  2. 2.2 Low Molecular Weight Heparin Sodium Industry Drivers
  3. 2.3 Low Molecular Weight Heparin Sodium Industry Opportunities and Challenges
  4. 2.4 Low Molecular Weight Heparin Sodium Industry Restraints
3 Low Molecular Weight Heparin Sodium Market by Manufacturers
  1. 3.1 Global Low Molecular Weight Heparin Sodium Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Low Molecular Weight Heparin Sodium Sales by Manufacturers (2021-2026)
  3. 3.3 Global Low Molecular Weight Heparin Sodium Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Low Molecular Weight Heparin Sodium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Low Molecular Weight Heparin Sodium Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Low Molecular Weight Heparin Sodium Manufacturers, Product Type & Application
  7. 3.7 Global Low Molecular Weight Heparin Sodium Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Low Molecular Weight Heparin Sodium Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Low Molecular Weight Heparin Sodium Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Low Molecular Weight Heparin Sodium Tier 1, Tier 2, and Tier 3
4 Low Molecular Weight Heparin Sodium Market by Type
  1. 4.1 Low Molecular Weight Heparin Sodium Type Introduction
  2. 4.1.1 Enoxaparin
  3. 4.1.2 Tinzaparin
  4. 4.1.3 Fraxiparine
  5. 4.1.4 Dalteparin
  6. 4.2 Global Low Molecular Weight Heparin Sodium Sales by Type
  7. 4.2.1 Global Low Molecular Weight Heparin Sodium Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Low Molecular Weight Heparin Sodium Sales by Type (2021-2032)
  9. 4.2.3 Global Low Molecular Weight Heparin Sodium Sales Market Share by Type (2021-2032)
  10. 4.3 Global Low Molecular Weight Heparin Sodium Revenue by Type
  11. 4.3.1 Global Low Molecular Weight Heparin Sodium Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Low Molecular Weight Heparin Sodium Revenue by Type (2021-2032)
  13. 4.3.3 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Type (2021-2032)
5 Low Molecular Weight Heparin Sodium Market by Application
  1. 5.1 Low Molecular Weight Heparin Sodium Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Research
  4. 5.2 Global Low Molecular Weight Heparin Sodium Sales by Application
  5. 5.2.1 Global Low Molecular Weight Heparin Sodium Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Low Molecular Weight Heparin Sodium Sales by Application (2021-2032)
  7. 5.2.3 Global Low Molecular Weight Heparin Sodium Sales Market Share by Application (2021-2032)
  8. 5.3 Global Low Molecular Weight Heparin Sodium Revenue by Application
  9. 5.3.1 Global Low Molecular Weight Heparin Sodium Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Low Molecular Weight Heparin Sodium Revenue by Application (2021-2032)
  11. 5.3.3 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Application (2021-2032)
6 Global Low Molecular Weight Heparin Sodium Sales by Region
  1. 6.1 Global Low Molecular Weight Heparin Sodium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Low Molecular Weight Heparin Sodium Sales by Region (2021-2032)
  3. 6.2.1 Global Low Molecular Weight Heparin Sodium Sales by Region (2021-2026)
  4. 6.2.2 Global Low Molecular Weight Heparin Sodium Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Low Molecular Weight Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Low Molecular Weight Heparin Sodium Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Low Molecular Weight Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Low Molecular Weight Heparin Sodium Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Low Molecular Weight Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Low Molecular Weight Heparin Sodium Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Low Molecular Weight Heparin Sodium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Low Molecular Weight Heparin Sodium Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Low Molecular Weight Heparin Sodium Revenue by Region
  1. 7.1 Global Low Molecular Weight Heparin Sodium Revenue by Region
  2. 7.1.1 Global Low Molecular Weight Heparin Sodium Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Low Molecular Weight Heparin Sodium Revenue by Region (2021-2026)
  4. 7.1.3 Global Low Molecular Weight Heparin Sodium Revenue by Region (2027-2032)
  5. 7.1.4 Global Low Molecular Weight Heparin Sodium Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Low Molecular Weight Heparin Sodium Revenue (2021-2032)
  8. 7.2.2 North America Low Molecular Weight Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Low Molecular Weight Heparin Sodium Revenue (2021-2032)
  11. 7.3.2 Europe Low Molecular Weight Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Low Molecular Weight Heparin Sodium Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Low Molecular Weight Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Low Molecular Weight Heparin Sodium Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Low Molecular Weight Heparin Sodium Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yantai Dongcheng Pharmaceutical Group
  2. 8.1.1 Yantai Dongcheng Pharmaceutical Group Company Information
  3. 8.1.2 Yantai Dongcheng Pharmaceutical Group Business Overview
  4. 8.1.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Sodium Product Portfolio
  6. 8.1.5 Yantai Dongcheng Pharmaceutical Group Recent Developments
  7. 8.2 Changzhou Qianhong Bio-pharma
  8. 8.2.1 Changzhou Qianhong Bio-pharma Company Information
  9. 8.2.2 Changzhou Qianhong Bio-pharma Business Overview
  10. 8.2.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Sodium Product Portfolio
  12. 8.2.5 Changzhou Qianhong Bio-pharma Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Low Molecular Weight Heparin Sodium Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Dongying Tiandong Pharmaceutica
  20. 8.4.1 Dongying Tiandong Pharmaceutica Company Information
  21. 8.4.2 Dongying Tiandong Pharmaceutica Business Overview
  22. 8.4.3 Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Dongying Tiandong Pharmaceutica Low Molecular Weight Heparin Sodium Product Portfolio
  24. 8.4.5 Dongying Tiandong Pharmaceutica Recent Developments
  25. 8.5 Techdow
  26. 8.5.1 Techdow Company Information
  27. 8.5.2 Techdow Business Overview
  28. 8.5.3 Techdow Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Techdow Low Molecular Weight Heparin Sodium Product Portfolio
  30. 8.5.5 Techdow Recent Developments
  31. 8.6 Sanofi-aventis
  32. 8.6.1 Sanofi-aventis Company Information
  33. 8.6.2 Sanofi-aventis Business Overview
  34. 8.6.3 Sanofi-aventis Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi-aventis Low Molecular Weight Heparin Sodium Product Portfolio
  36. 8.6.5 Sanofi-aventis Recent Developments
  37. 8.7 Opocrin
  38. 8.7.1 Opocrin Company Information
  39. 8.7.2 Opocrin Business Overview
  40. 8.7.3 Opocrin Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Opocrin Low Molecular Weight Heparin Sodium Product Portfolio
  42. 8.7.5 Opocrin Recent Developments
  43. 8.8 CSBIO
  44. 8.8.1 CSBIO Company Information
  45. 8.8.2 CSBIO Business Overview
  46. 8.8.3 CSBIO Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CSBIO Low Molecular Weight Heparin Sodium Product Portfolio
  48. 8.8.5 CSBIO Recent Developments
  49. 8.9 Aspen
  50. 8.9.1 Aspen Company Information
  51. 8.9.2 Aspen Business Overview
  52. 8.9.3 Aspen Low Molecular Weight Heparin Sodium Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Aspen Low Molecular Weight Heparin Sodium Product Portfolio
  54. 8.9.5 Aspen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Low Molecular Weight Heparin Sodium Value Chain Analysis
  2. 9.1.1 Low Molecular Weight Heparin Sodium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Low Molecular Weight Heparin Sodium Production Mode & Process
  6. 9.2 Low Molecular Weight Heparin Sodium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Low Molecular Weight Heparin Sodium Distributors
  9. 9.2.3 Low Molecular Weight Heparin Sodium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst